SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the Society for Gynecologic Investigation
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Marks, T. A.
Right arrow Articles by Gibbs, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, T. A.
Right arrow Articles by Shroyer, K. R.
Right arrow Articles by Markham, N. E.
Right arrow Articles by Slocumb, J. C.
Right arrow Articles by Gibbs, R. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Clinical, Histologic, and DNA Study of Vulvodynai and Its Association With Human Papillomavirus

Tari A. Marks

Kenneth R. Shroyer, MD, PhD

Neil E. Markham

John C. Slocumb, MD, MPH

Ronald S. Gibbs, MD

Departments of Obstetrics and Gynecology and Pathology, University of Colorado Health Sciences Center, Denver, Colorado

Objective: To compare the clinical and histologic characteristics of vulvodynia with or without associated human papillomavirus (HPV) DNA, as determined by polymerase chain reaction (PCR).

Methods: We conducted a standardized chart review of patients referred for vulvodynia lasting for more than 3 months and systematically reviewed all vulvar biopsy specimens histologically. In addition, specimens were amplified by PCR followed by Southern blot hybridization to detect HPV DNA, and possitive cases were typed using the Hybrid Capture system.

Results: Of 55 cases, 48 were evlauable by PCR. Human papillomavrius DNA was detected in 35% (17 of 48), including 44% (four of nine) of normal cases, 25% (eight of 32) with reactive squamous atypia, 67% (four of six) with condyloma/mild dysplasia, and 100% (one of one) with moderate/svere dysplasia. Patients who were positive for HPV DNA (n = 17) were not significantly different from HPV-negative patients (n = 31) for any of 82 clinical or epidemiologic variables. When patients with normal biopsies (n = 9) were compared to those with reactive squamous atypia (n = 39), there were significant differences in only two of 82 variables (duration of symptoms and current sexual activity). Of the 17 HPV-positive cases, 13 were typeable by the Hybrid Capture system. Fiv (38%) were positive for low-risk HPV types, three (23%) were positive for high-risk HPV types, and five (38%) were positive for both low- and high-risk types.

Conclusions: Vulvodynia associated with HPV DNA is clinically identical to vulvodynia without HPA DNA, and vulvodynia associated with normal biopsy findings is very similar to that with reactive squamous atypia. These data suggest that HPV does not cause vulvodynia.

Key Words: DNA • vulvodynia • papillomavirus • histology • PCR

Journal of the Society for Gynecologic Investigation, Vol. 2, No. 1, 57-63 (1995)
DOI: 10.1177/107155769500200111


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement